Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no single clinically mandated time of day to take Wegovy. The licensed schedule requires one weekly subcutaneous injection, and the day of the week can be yours to choose — but the time within that day is not specified in the UK product licence. That said, many people find that injecting in the evening suits them, and there are practical reasons why. Because Wegovy (semaglutide) is a GLP-1 receptor agonist and a prescription-only medicine, questions about your personal timing should always be settled with the prescriber or pharmacist who issued your prescription, the guidance below explains what the evidence and the licensed information actually say, so you can have that conversation well-prepared.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: you injected on a Saturday morning, ate breakfast an hour later, and spent most of the afternoon feeling queasy. It is one of the questions our prescribers hear most weeks. The good news is that the timing of your dose can often be shifted without any clinical downside, because the Wegovy pre-filled pen is designed around a once-weekly rhythm, not a once-daily window tied to meals or sleep. The licensed patient information does not specify morning versus evening; it tells you to pick a day and stick to it.
Nausea, indigestion and fatigue are the most frequently reported early effects of semaglutide, as documented on the NHS semaglutide medicines page. These are usually most noticeable in the 24–48 hours after a dose increase and tend to settle as your body adjusts. Sleeping through those first few hours is a straightforward strategy that many people find genuinely helpful. There is a common assumption that evening injections somehow alter how the medicine works, they do not. Semaglutide's half-life is approximately one week, which is why it is dosed weekly in the first place; a few hours in either direction has no meaningful effect on blood levels or efficacy.
One practical note: if you inject at night, make sure your pen has been stored correctly in the fridge beforehand. Taking it straight from a cold fridge and injecting immediately can cause brief discomfort at the site. Letting it sit at room temperature for a few minutes first is a small comfort measure worth knowing. The exact room-temperature storage window is set out in the Patient Information Leaflet that comes with your pen, check there rather than relying on any general figure you read online.
Evening dosing is not a universal answer. Some people manage GI side effects well and prefer to inject in the morning so the dose is part of a predictable daily routine. If your main concern is not nausea but rather remembering to inject consistently, a morning slot tied to something fixed (before the kettle boils, say, or before a shower) can improve adherence reliably. Adherence to the titration schedule matters: missing doses, or injecting erratically, can disrupt the gradual dose-escalation process that the starting 0.25mg maintenance pathway is built around.
There is also a fatigue consideration. A minority of people feel tired in the hours after an injection. For them, a morning injection might mean a sluggish afternoon rather than a restless night. Neither experience is dangerous, but knowing which pattern applies to you takes a dose or two to figure out. Tracking how you feel on your current schedule for two to three weeks is more useful than switching immediately at the first sign of discomfort.
If you are comparing how different timing approaches might fit alongside your lifestyle more broadly, and are also curious about whether Wegovy is the right option for you compared with alternatives, this guide comparing night versus morning dosing in more detail covers the practical trade-offs further. The short version: try what makes sense for your routine, give it a few weeks, and adjust if your prescriber agrees it is sensible to do so.
Timing is one lever. Diet is often a bigger one. Fatty or heavily processed meals eaten close to an injection can amplify nausea and reflux, regardless of whether you injected at 8am or 10pm. Keeping portions moderate, eating slowly and avoiding very rich food in the hours around your dose tends to make a meaningful difference. Hydration matters too, GI symptoms can concentrate dehydration risks in people who are not drinking enough, particularly in the early weeks.
There is a small but important safety point worth naming clearly. Severe, persistent stomach pain that spreads to the back is not a typical GI side effect. It is a symptom that needs prompt medical attention, as the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines and acute pancreatitis. That guidance is relevant regardless of when you take your dose. If you experience it, contact a doctor without delay. For less urgent questions about your side-effect pattern, the prescriber who manages your treatment is the right first call, not a forum or a general search result.
For anyone considering starting Wegovy for the first time and wondering how to approach these practical questions, this page on whether it is appropriate to inject at night addresses eligibility and the clinical assessment process, and you can read more about weight-loss treatment options if you are still at the stage of working out which medicine might suit you.
The best timing is the one you will actually stick to, week after week. That sounds obvious, but it is the correct clinical answer. A prescriber reviewing your case can take your work schedule, your side-effect history, any other medicines you take and your injection-site rotation into account in a way that a general article cannot.
At nume, every repeat prescription involves a clinical review by a GPhC-registered Independent Prescriber, a real clinician looks at your record, not software running a checklist. If your current timing is not working, that is exactly the kind of thing worth raising. You can find out more about our clinical team or read through common questions about treatment if you want a sense of how the process works before you start.
For context on what treatment privately involves, including what a single transparent price covers, this page on accessing Wegovy through a regulated UK pharmacy sets that out plainly. When you are ready to check whether you meet the criteria for treatment, checking your eligibility through a free consultation is the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.